Wind recently released “China’s Top 500 Listed Companies by Market Value” in first half of 2021, and China Medical System Holdings Limited (“CMS” or the “Group”) ranked 497 with a market value of RMB42 billion, up 77 places from the previous ranking.
With the deepening reform in the pharmaceutical industry, CMS has been actively thinking and striving forward, accelerating the investment and development of innovative patented drugs. While promoting the in-depth development of the pharmaceutical business, the Group has constantly expanded its boundaries and entered into the fields of medical aesthetics and healthcare via leveraging its commercialization platform, laying a solid foundation for the Group’s long-term development.